Title |
Bench-to-bedside review: Targeting antioxidants to mitochondria in sepsis
|
---|---|
Published in |
Critical Care, August 2010
|
DOI | 10.1186/cc9098 |
Pubmed ID | |
Authors |
Helen F Galley |
Abstract |
Development of organ dysfunction associated with sepsis is now accepted to be due at least in part to oxidative damage to mitochondria. Under normal circumstances, complex interacting antioxidant defense systems control oxidative stress within mitochondria. However, no studies have yet provided conclusive evidence of the beneficial effect of antioxidant supplementation in patients with sepsis. This may be because the antioxidants are not accumulating in the mitochondria, where they are most needed. Antioxidants can be targeted selectively to mitochondria by several means. This review describes the in vitro studies and animal models of several diseases involving oxidative stress, including sepsis, in which antioxidants targeted at mitochondria have shown promise, and the future implications for such approaches in patients. |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 3 | 3% |
Brazil | 2 | 2% |
France | 1 | <1% |
Indonesia | 1 | <1% |
Chile | 1 | <1% |
Mexico | 1 | <1% |
Unknown | 101 | 92% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Master | 17 | 15% |
Student > Ph. D. Student | 16 | 15% |
Researcher | 15 | 14% |
Student > Bachelor | 11 | 10% |
Student > Doctoral Student | 10 | 9% |
Other | 27 | 25% |
Unknown | 14 | 13% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 48 | 44% |
Agricultural and Biological Sciences | 23 | 21% |
Biochemistry, Genetics and Molecular Biology | 11 | 10% |
Pharmacology, Toxicology and Pharmaceutical Science | 4 | 4% |
Chemistry | 3 | 3% |
Other | 6 | 5% |
Unknown | 15 | 14% |